东北农业大学学报
東北農業大學學報
동북농업대학학보
JOURNAL OF NORTHEAST AGRICULTURAL UNIVERSITY
2014年
12期
31-35
,共5页
孙燕%万冰%金戈%张玉丽%郭丽%马铃铃%张梦月
孫燕%萬冰%金戈%張玉麗%郭麗%馬鈴鈴%張夢月
손연%만빙%금과%장옥려%곽려%마령령%장몽월
黄连解毒汤%S180%环氧合酶- 2%血管内皮生长因子%碱性成纤维细胞生长因子
黃連解毒湯%S180%環氧閤酶- 2%血管內皮生長因子%堿性成纖維細胞生長因子
황련해독탕%S180%배양합매- 2%혈관내피생장인자%감성성섬유세포생장인자
Huanglianjiedu Decoction (HLJDT)%S180%COX-2%VEGF%bFGF
研究黄连解毒汤(HLJDT)对肿瘤生长的抑制作用及其对肿瘤组织COX-2、VEGF、bFGF的影响。将健康雌性昆明种小鼠50只(体重18~22 g)随机分为对照组,环磷酰胺组(CTX),黄连解毒汤大、中、小剂量组(22.0、11.0、5.5 g·kg-1)。通过皮下注射S180细胞悬液建立小鼠S180肉瘤模型,观察抑瘤率,并采用免疫组化的方法研究黄连解毒汤对肿瘤组织COX-2、VEGF、bFGF的作用。结果表明,黄连解毒汤大剂量组对小鼠S180肉瘤具有明显的抑制作用,免疫组化染色显示黄连解毒汤各剂量组对肿瘤组织中COX-2、bFGF表达有明显抑制作用,同时大、中剂量组对VEGF表达有明显抑制作用。说明黄连解毒汤对S180肉瘤具有抑制作用,其可抑制肿瘤组织中血管生成相关因子COX-2、VEGF、bFGF的表达,抑制肿瘤血管生长,抑制肿瘤生长,抗血管生成可能是其发挥治疗作用的另一种机制。
研究黃連解毒湯(HLJDT)對腫瘤生長的抑製作用及其對腫瘤組織COX-2、VEGF、bFGF的影響。將健康雌性昆明種小鼠50隻(體重18~22 g)隨機分為對照組,環燐酰胺組(CTX),黃連解毒湯大、中、小劑量組(22.0、11.0、5.5 g·kg-1)。通過皮下註射S180細胞懸液建立小鼠S180肉瘤模型,觀察抑瘤率,併採用免疫組化的方法研究黃連解毒湯對腫瘤組織COX-2、VEGF、bFGF的作用。結果錶明,黃連解毒湯大劑量組對小鼠S180肉瘤具有明顯的抑製作用,免疫組化染色顯示黃連解毒湯各劑量組對腫瘤組織中COX-2、bFGF錶達有明顯抑製作用,同時大、中劑量組對VEGF錶達有明顯抑製作用。說明黃連解毒湯對S180肉瘤具有抑製作用,其可抑製腫瘤組織中血管生成相關因子COX-2、VEGF、bFGF的錶達,抑製腫瘤血管生長,抑製腫瘤生長,抗血管生成可能是其髮揮治療作用的另一種機製。
연구황련해독탕(HLJDT)대종류생장적억제작용급기대종류조직COX-2、VEGF、bFGF적영향。장건강자성곤명충소서50지(체중18~22 g)수궤분위대조조,배린선알조(CTX),황련해독탕대、중、소제량조(22.0、11.0、5.5 g·kg-1)。통과피하주사S180세포현액건립소서S180육류모형,관찰억류솔,병채용면역조화적방법연구황련해독탕대종류조직COX-2、VEGF、bFGF적작용。결과표명,황련해독탕대제량조대소서S180육류구유명현적억제작용,면역조화염색현시황련해독탕각제량조대종류조직중COX-2、bFGF표체유명현억제작용,동시대、중제량조대VEGF표체유명현억제작용。설명황련해독탕대S180육류구유억제작용,기가억제종류조직중혈관생성상관인자COX-2、VEGF、bFGF적표체,억제종류혈관생장,억제종류생장,항혈관생성가능시기발휘치료작용적령일충궤제。
The experiments were designed to study the effects of Huanglianjiedu Decoction(HLJDT) on antitumor activity in vivo and the expressions of COX-2, VEGF and bFGF in tumor tissues. 50 healthy female Kunming mice(18-22 g) were col ected, 50 tumor-bearing mice were randomly divided into NS control group, CTX positive group and 22.0, 11.0, 5.5 g·kg-1 HLJDT groups. We established S180 model of mice by transplanting 0.2 mL S180 cel suspension subcutaneously in mice, and immunohistochemical method was used to detect the expressions of COX-2, VEGF and bFGF.The results showed that the tumor-suppressing rate was higher in CTX group and HLJDT high dose group. COX-2 and bFGF in HLJDT groups and CTX group was lower than that in model group significantly. And the expressions of VEGF in HLJDT medium dose group and high dose group were markedly lower than that in model group. The results suggested that HLJDT had inhibitory effects on S180, and it also decreased the expression of COX-2, VEGF, bFGF in tumor tissue. Accordingly antiangiogenesis may be another mechanism for HLJDT to exert its treatment effects.